Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR5 | P32302 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | BAD | Q92934 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 3/20 | 0.40 |
| ▸ | RXRB | P28702 | 3/20 | 0.40 |
| ▸ | RXRG | P48443 | 3/20 | 0.40 |
| ▸ | FABP4 | P15090 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3124135 | 0.89 | BCL2L1 (0.52) | CXCR5L3MBTL1ALOX15MAPK1CASP1 | |
| SCHEMBL29351721 | 0.85 | PARP1 (0.51) | CXCR5L3MBTL1ALOX15MAPK1CASP1 | |
| SCHEMBL3434922 | 0.85 | PARP1 (0.51) | CXCR5L3MBTL1ALOX15MAPK1CASP1 | |
| Hydrochloric Acid SCHEMBL30363549 | 0.84 | PARP1 (0.50) | CXCR5L3MBTL1ALOX15MAPK1CASP1 | |
| Trifluoroacetic Acid SCHEMBL3728784 | 0.81 | BCL2L1 (0.44) | CXCR5L3MBTL1BCL2L1BADMEN1 | |
| SCHEMBL783869 | 0.78 | CXCR5 (0.56) | CXCR5L3MBTL1ALOX15BCL2L1BAD | |
| SCHEMBL29493191 | 0.78 | CXCR5 (0.56) | CXCR5L3MBTL1ALOX15BCL2L1BAD | |
| Hydrochloric Acid SCHEMBL2398251 | 0.77 | CXCR5 (0.55) | CXCR5L3MBTL1ALOX15BCL2L1BAD | |
| SCHEMBL5755502 | 0.77 | CXCR5 (0.55) | CXCR5L3MBTL1ALOX15BCL2L1BAD | |
| SCHEMBL11006528 | 0.76 | HTR7 (0.49) | CXCR5L3MBTL1ALOX15MAPK1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2457896-A1 | Tripeptides as caspase modulators | Idun Pharmaceuticals, Inc. (US) | 2012-05-30 | — | — | EP | disclosed |
| EP-2457895-A1 | Tetrapeptide analogs | Idun Pharmaceuticals, Inc. (US) | 2012-05-30 | — | — | EP | disclosed |
| US-20100190688-A1 | Tetrapeptide analogs | IDUN PHARMACEUTICALS, INC. | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190688-A1 | Tetrapeptide analogs | TP53, PCNA, HRAS | CXCR5 2337/4885L3MBTL1 99/4885ALOX15 4123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.